Average Co-Inventor Count = 6.19
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (10 from 4,179 patents)
2. Abbvie Inc. (7 from 822 patents)
3. Galapagos Nv (4 from 116 patents)
4. Abbvie S.a.r.l. (4 from 15 patents)
5. Calico Life Sciences LLC (1 from 5 patents)
6. Abbvie Overseas Sarl (5 patents)
21 patents:
1. 11149043 - Prodrug modulators of the integrated stress pathway
2. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
3. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
4. 10130622 - Compounds for treatment of cystic fibrosis
5. 10053474 - Anti-viral compounds
6. 9890158 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
7. 8859549 - Potassium channel modulators
8. 8815930 - Compounds that inhibit TRPV1 and uses thereof
9. 8629143 - Potassium channel modulators
10. 8598220 - Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
11. 8440691 - Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
12. 8232309 - Prodrugs of compounds that inhibit TRPV1 receptor
13. 7998982 - Amide derivatives as TRPV1 antagonists
14. 7812019 - Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
15. 7767705 - Compounds that inhibit TRPV1 and uses thereof